HealthEquity Analyst Price Targets

HealthEquity Inc

HQYNASDAQ

$96.07

-2.71-2.74%

In chiusura: Sep 4, 5:00 PM EST

$96.07

N/A

Post-mercato: Sep 4, 6:32 PM EST

Wall Street analyst price targets and consensus rating for HealthEquity (HQY).

Price Target Range — 13 Quarters

Analyst Consensus — 17 Analysts

3S.Buy

13Buy

1Sell

Consensus RatingOutperform# Analysts17Avg. Consensus PT$116Upside to Avg. PT+20.2%

Rating Trend — Last 9 Months

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 31, 2026	Deutsche Bank	George Hill	PT Raise	Buy	$135→$142
Aug 28, 2026	BTIG	David Larsen	Maintained	Buy	$115
Jul 24, 2026	BTIG	David Larsen	PT Raise	Buy	$110→$115
Jun 3, 2026	RBC Capital	Ryan Halsted	Maintained	Outperform	$108
Jun 1, 2026	Citizens	Constantine Davides	PT Raise	Market Outperform	$110→$111
May 29, 2026	RBC Capital	Ryan Halsted	PT Raise	Outperform	$100→$108
May 22, 2026	Barrington Research	Alexander Paris	Maintained	Outperform	$110
Apr 9, 2026	BMO Capital	Sean Dodge	Upgrade	Market Perform→Outperform	$85→$105
Mar 19, 2026	Deutsche Bank	George Hill	PT Raise	Buy	$120→$128
Mar 18, 2026	Barrington Research	Alexander Paris	PT Cut	Outperform	$125→$110
Mar 18, 2026	JP Morgan	Alexei Gogolev	PT Cut	Overweight	$129→$123
Mar 18, 2026	RBC Capital	Daniel R. Perlin	PT Cut	Outperform	$110→$100
Feb 18, 2026	Barclays	Glen Santangelo	PT Cut	Overweight	$118→$110
Feb 17, 2026	BTIG	David Larsen	PT Cut	Buy	$130→$110
Jan 9, 2026	Goldman Sachs	David Roman	Downgrade	Neutral→Sell	$89
Jan 8, 2026	Keybanc	Scott Schoenhaus	PT Raise	Overweight	$120→$125
Dec 9, 2025	Barclays	Glen Santangelo	Initiate	Overweight	$118
Dec 4, 2025	Barrington Research	Alexander Paris	Maintained	Outperform	$125
Dec 4, 2025	JP Morgan	Alexei Gogolev	PT Raise	Overweight	$126→$129
Dec 4, 2025	Citizens	Constantine Davides	PT Raise	Market Outperform	$117→$122